with this disappointing report, the company is ushering in something Business Insider's Sam Ro warned could be coming: a turbulent earnings season.
Period Ending Jun 30, 2014 Jun 30, 2013 Jun 30, 2012
Net Income (830) (1,443) (11,434)
Operating Activities, Cash Flows Provided By or Used In
Depreciation 83 43 10,501
Adjustments To Net Income 254 987 427
Changes In Accounts Receivables - - -
Changes In Liabilities 265 282 335
Changes In Inventories - - -
Changes In Other Operating Activities 0 2 1
Total Cash Flow From Operating Activities (226) (129) (170)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures - - -
Investments - - -
Other Cash flows from Investing Activities - - -
Total Cash Flows From Investing Activities - - -
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid - - -
Sale Purchase of Stock - - 28
Net Borrowings 311 128 142
Other Cash Flows from Financing Activities - - -
Total Cash Flows From Financing Activities 311 128 170
Effect Of Exchange Rate Changes 3 0 (0)
Change In Cash and Cash Equivalents 88 (0) 0
NO , why today LAS VEGAS with Cemtrex, Inc. (CETX) and Can-Fite BioPharma Ltd. (CANF) ??????????
It is PAN candidate unless breaks 0.059
I will stay away from this co unless it makes a move towards 0.06.
Chart telling me About bullish and bearish volume and the ways of recognizing bullish and bearish volume bars and periods.: real bad
I like to see retest first of last two weeks.If does it again then it is a strong buy.
but for write now any upside move is a sell up to 0.059
Love the volume